plerixafor has been researched along with Agammaglobulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Shoshan, M; Jfri, A; Litvinov, IV; Merati, N; Popradi, G; Sivachandran, S; Vinh, DC | 1 |
| Badolato, R; Dotta, L; Tassone, L | 1 |
2 review(s) available for plerixafor and Agammaglobulinemia
| Article | Year |
|---|---|
Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
Topics: Agammaglobulinemia; Benzylamines; Cyclams; Fantasy; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Neutropenia; Papillomavirus Infections; Primary Immunodeficiency Diseases; Receptors, CXCR4; Syndrome; Warts | 2022 |
Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Bacterial Infections; Benzylamines; Bone Marrow; Chemokine CXCL12; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Humans; Immunologic Deficiency Syndromes; Lymphopenia; Male; Mutation; Neutropenia; Neutrophils; Primary Immunodeficiency Diseases; Receptors, CXCR4; Signal Transduction; Warts | 2011 |